Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?
- Published In:
- International journal of oral and maxillofacial surgery, 54(9), 806-808 (2025)
- Authors:
- Yassin Alsabbagh, A, Bhujel, N, Singh, R P
- Database ID:
- RPEP-14362
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14362APA
Yassin Alsabbagh, A; Bhujel, N; Singh, R P. (2025). Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?. International journal of oral and maxillofacial surgery, 54(9), 806-808. https://doi.org/10.1016/j.ijom.2025.03.014
MLA
Yassin Alsabbagh, A, et al. "Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?." International journal of oral and maxillofacial surgery, 2025. https://doi.org/10.1016/j.ijom.2025.03.014
RethinkPeptides
RethinkPeptides Research Database. "Melanotan II nasal spray: a possible risk factor for oral mu..." RPEP-14362. Retrieved from https://rethinkpeptides.com/research/yassin-2025-melanotan-ii-nasal-spray
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.